The following is a description of a study from one of the many researchers that our organization has funded.

Xin Dong, Ph.D.
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
More than 80 percent of rheumatoid arthritis patients produce antibodies against their own immune system, called rheumatoid factors. It is believed that rheumatoid factor production by B cells is controlled by specific “antibody-reactive” T cells. Dr. Dong is studying the T cells thought to produce rheumatoid factors. This work may lead to the design of drugs or therapeutic strategies to inhibit these specific T cells from producing autoantibodies.
You may return to the list of research that we have funded.